30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Garen Bohlin

Track

Insider profile

Currently holds positions in Acusphere Inc, Tetraphase Pharmaceuticals Inc, Karyopharm Therapeutics Inc, Protara Therapeutics Inc and Collegium Pharmaceutical Inc

Performance

Overall performance
2.0
Performance over holding periods
2.0
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Acusphere Inc Jan. 25, 2005 -
Independent Director Tetraphase Pharmaceuticals Inc July 1, 2010 -
Independent Director Karyopharm Therapeutics Inc Oct. 1, 2013 -
Independent Director Protara Therapeutics Inc Sept. 1, 2014 -
Independent Director Collegium Pharmaceutical Inc Jan. 1, 2015 -
Executive Vice President Constellation Pharmaceuticals Inc None -
Garen Bohlin's trades of Collegium Pharmaceutical Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-13 2026-05-11
S Sale
59,573 +43.5%
474.35
US$1,062,832 		59,573 +43.5% 474.35 US$1,062,832
2026-05-11 2026-05-11
PrS Proposed sale
37,887
117.90
US$2,514,052 		37,887 117.90 US$2,514,052
2024-05-16 2024-05-14
S Sale
31,076 +44.9%
234.76
US$2,597,664 		31,076 +44.9% 234.76 US$2,597,664
2024-05-14 2024-05-14
PrS Proposed sale
28,985
32.30
US$936,311 		28,985 32.30 US$936,311
2023-09-12 2023-09-12
B Purchase
41,140 +1028.5%
1.22
US$49,985 		41,140 +1028.5% 1.22 US$49,985